NCT00371501View on ClinicalTrials.gov

Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
AtherosclerosisThromboembolismSystemic Lupus Erythematosus
Interventions
DRUG

Rosuvastatin

10mg/day

DRUG

placebo

one tablet/day

DRUG

aspirin

80mg/day

DRUG

placebo

placebo

Trial Locations (1)

Unknown

Tuen Mun Hospital, Hong Kong

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Tuen Mun Hospital

OTHER_GOV